한글목차

세계의 웨어러블 주사기 시장은 2024년에 86억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 9.89%로 성장하여 151억 8,000만 달러에 달할 것으로 예측됩니다.

웨어러블 주사기는 제어된 피하 약물전달을 목적으로 하는 소형 의료기기로, 신체에 착용하여 편리하고 눈에 띄지 않게 약물을 투여할 수 있습니다. 이 시장의 성장은 주로 지속적인 자가 치료가 필요한 만성질환의 전 세계 유병률 증가와 환자의 자율성을 높여주는 재택의료 솔루션에 대한 수요 증가에 힘입은 바 큽니다.

주요 시장 촉진요인

전 세계적으로 만성질환의 유병률이 증가함에 따라 웨어러블 주사기 시장의 주요 촉진요인으로 작용하고 있습니다. 이를 위해서는 지속적이고 복잡한 약물 투여가 필요합니다. 당뇨병, 심혈관질환, 자가면역질환 등의 질환은 장기간에 걸친 정기적이고 정확한 투약이 필요하며, 편의성이 높은 투약 방법이 매우 중요합니다.

주요 시장 과제

첨단 웨어러블 주사기 개발에 따른 높은 초기 비용은 세계 웨어러블 주사기 시장의 큰 도전 과제입니다. 이러한 막대한 자금 투입은 최종 제품의 가격 상승을 통해 시장 확대를 직접적으로 저해하고, 보급에 걸림돌이 될 수 있습니다.

주요 시장 동향

원활한 디지털 통합과 원격 모니터링은 실시간 데이터 교환 및 환자 모니터링을 위한 연결성을 통합하여 웨어러블 주사기를 변화시키고 있습니다. 이 기능을 통해 복약 순응도, 기기 성능, 환자의 생리적 반응을 지속적으로 추적할 수 있어 보다 정보에 입각한 치료 조정을 가능하게 합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(장착형, 비장착형)
  • 기술별(링식, 모터 구동식, 로터리 펌프식, 확장형 배터리식, 기타)
  • 용도별(종양학, 감염증, 심혈관질환, 자가면역질환, 면역결핍, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 웨어러블 주사기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 웨어러블 주사기 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Becton & Dickinson Co.
• Johnson & Johnson Service Inc.
• F. Hoffmann-La Roche Ltd.
• Frederick Furness Publishing Ltd
• Steady Med Therapeutics, Inc(United Therapeutics Corporation)
• Amgen Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Wearable Injectors Market, valued at USD 8.62 Billion in 2024, is projected to experience a CAGR of 9.89% to reach USD 15.18 Billion by 2030. Wearable injectors are compact medical devices designed for controlled subcutaneous drug delivery, worn on the body to facilitate convenient and discreet medication administration. Growth in this market is primarily supported by the increasing global prevalence of chronic diseases requiring continuous self-treatment and the expanding demand for home-based healthcare solutions, which enhance patient autonomy.

Key Market Drivers

The increasing global prevalence of chronic diseases represents a primary driver for the wearable injectors market, necessitating continuous and often complex drug administration. Conditions like diabetes, cardiovascular disease, and autoimmune disorders demand regular, precise dosing over extended periods, making convenient delivery crucial. Wearable injectors offer an effective solution, enabling patients to manage therapies outside clinical settings, thereby supporting adherence and improving quality of life. Addressing this expanding patient population, according to Novo Nordisk, February 2025, Novo Nordisk Annual Report 2024, the company served over 45.2 million people living with serious chronic diseases in 2024, highlighting the critical demand for accessible drug delivery systems.

Key Market Challenges

The high initial cost associated with developing advanced wearable injectors presents a significant challenge to the Global Wearable Injectors Market. This substantial financial outlay directly hampers market expansion by elevating the final product price, which can limit widespread adoption. Such cost implications are particularly pronounced in regions with constrained healthcare budgets or limited reimbursement coverage, making these innovative devices less accessible to a broader patient population requiring continuous self-treatment.

Key Market Trends

Seamless digital integration and remote monitoring are transforming wearable injectors by embedding connectivity for real-time data exchange and patient oversight. This capability allows for continuous tracking of adherence, device performance, and patient physiological responses, leading to more informed treatment adjustments. According to France Biotech, in 2023, remote monitoring solutions demonstrated the highest growth in the digital health sector, increasing by four points compared to 2022 to represent 14% of digital health products. This integration supports decentralized care by extending clinical supervision into the home setting, improving patient safety and engagement.

Key Market Players

• Becton & Dickinson Co.
• Johnson & Johnson Service Inc.
• F. Hoffmann-La Roche Ltd.
• Frederick Furness Publishing Ltd
• Steady Med Therapeutics, Inc (United Therapeutics Corporation)
• Amgen Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

Report Scope:

In this report, the Global Wearable Injectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wearable Injectors Market, By Type:

• On-body
• Off-body

Wearable Injectors Market, By Technology:

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Other

Wearable Injectors Market, By Application:

• Oncology
• Infectious Disease
• Cardiovascular Disease
• Autoimmune Disease
• Immunodeficiency
• others

Wearable Injectors Market, By Region:

• North America
• South America
• Asia Pacific
• Europe
• MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Wearable Injectors Market.

Available Customizations:

Global Wearable Injectors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wearable Injectors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (On-body, Off-body)
  • 5.2.2. By Technology (ring-based, Motor-driven, Rotary Pump, Expanding Battery, Other)
  • 5.2.3. By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Immunodeficiency, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Wearable Injectors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wearable Injectors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Wearable Injectors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Wearable Injectors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application

7. Europe Wearable Injectors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wearable Injectors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. France Wearable Injectors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Wearable Injectors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Wearable Injectors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Wearable Injectors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. Asia Pacific Wearable Injectors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wearable Injectors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. India Wearable Injectors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Wearable Injectors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Wearable Injectors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Wearable Injectors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application

9. Middle East & Africa Wearable Injectors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wearable Injectors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Wearable Injectors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Wearable Injectors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. South America Wearable Injectors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wearable Injectors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Wearable Injectors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Wearable Injectors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wearable Injectors Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton & Dickinson Co.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Johnson & Johnson Service Inc.
• 15.3. F. Hoffmann-La Roche Ltd.
• 15.4. Frederick Furness Publishing Ltd
• 15.5. Steady Med Therapeutics, Inc (United Therapeutics Corporation)
• 15.6. Amgen Inc.
• 15.7. Insulet Corporation
• 15.8. Enable Injections
• 15.9. West Pharmaceutical Services, Inc.
• 15.10. CeQur SA

16. Strategic Recommendations

17. About Us & Disclaimer